Depression is officially classified as a psychiatric disorder, not a neurological one. But the biology underneath it tells a more complicated story. Brain imaging studies show measurable shrinkage in key regions, neurochemical imbalances affect multiple signaling systems, and inflammation pathways overlap heavily with those seen in recognized neurological diseases. The line between “neurological” and “psychiatric” turns out to be far less scientific than most people assume, and depression sits squarely in the territory where that line breaks down.
Why the Neurology-Psychiatry Split Exists at All
If you tried to explain to someone unfamiliar with medicine why Parkinson’s disease belongs to neurology but depression belongs to psychiatry, you’d run into trouble fast. Both involve the brain. Both involve disrupted neurotransmitter systems. Both alter mood, movement, and cognition. The historical split between neurology and psychiatry has more to do with how medicine organized itself in the 19th and 20th centuries than with any clean biological boundary. As one analysis put it, diseases of the brain are generally sorted into neurological or psychiatric categories, but they “cannot be readily separated on the basis of pathophysiology or symptomatology,” and the division is “untenable” when examined from first principles.1PubMed Central. The neurology-psychiatry divide: a thought experiment
In practice, neurology has traditionally claimed conditions where a visible lesion, structural abnormality, or measurable electrical dysfunction can be identified on a scan or test. Psychiatry has claimed the conditions where those visible markers were harder to pin down, so diagnosis relied on behavioral symptoms and patient reports. But that distinction has eroded steadily as brain imaging and molecular biology have improved. Depression, it turns out, has plenty of visible markers. They’re just distributed across many systems rather than concentrated in one obvious lesion.
Measurable Brain Changes in Depression
One of the most consistent findings in depression research involves the hippocampus, a brain region central to memory and emotional regulation. A pooled analysis of brain-imaging studies found that even people experiencing their first episode of depression already show hippocampal volume loss compared to healthy controls, with an average reduction of about 4% on the left side and roughly 4.5% on the right.2PubMed. Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies That finding is significant because it means the shrinkage isn’t purely a consequence of years of illness or medication. Something about the depressive process itself appears to affect brain volume early on.
At the chemical level, depression involves disruptions in both excitatory and inhibitory signaling. Research has documented structural, functional, and neurochemical deficits in both glutamate neurons (the brain’s main excitatory cells) and GABA interneurons (the main inhibitory cells), which could degrade how accurately signals travel through the cortex and hippocampus.3PubMed Central. Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments This isn’t just a matter of “low serotonin,” the popular explanation that has dominated public understanding for decades. The neurochemical picture is broader, involving multiple transmitter systems interacting with each other.
Another piece of the puzzle involves a molecule called BDNF, a growth factor that supports the survival and branching of neurons. Studies consistently find that lower BDNF levels are linked to more depressive symptoms, neuronal loss, and cortical atrophy.4PubMed Central. BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions In animal models, blocking BDNF increases depression-like behavior, while stress reduces BDNF production, impairing the brain’s structural plasticity. This impaired plasticity may be an early driver of the condition rather than a downstream consequence.5Frontiers in Cellular Neuroscience. The Role of BDNF on Neural Plasticity in Depression
Network-Level Disruptions
Depression doesn’t just affect individual brain regions in isolation. It disrupts how large-scale networks communicate. One network that has received substantial attention is the default mode network (DMN), a set of brain areas that becomes active during self-referential thinking, daydreaming, and introspection. In people at risk for depression, hearing criticism triggers exaggerated activity in DMN regions, particularly the medial prefrontal cortex, compared to people without that risk profile. That heightened DMN response after criticism was correlated with rumination, the repetitive, self-focused negative thinking that characterizes much of the depressive experience.6PubMed Central. The default mode network and rumination in individuals at risk for depression
Machine learning studies have pushed this further. Using resting-state brain scans and graph-based algorithms, researchers have been able to distinguish people with depression from healthy controls with over 80% accuracy. The brain regions that contributed most to the classification were located in the DMN, the frontoparietal network, and the cingulo-opercular network, spanning the anterior cingulate cortex, prefrontal cortex, and inferior parietal lobule among others.7The Lancet. Identification of distinct depression biotypes using resting-state functional MRI and machine learning The fact that a computer can read network-level disruptions from a brain scan and identify depression with that level of accuracy suggests the disorder has a neurological signature, even if the medical system doesn’t classify it that way.
Inflammation Crossing Into the Brain
One of the most active areas of depression research in recent years has been neuroinflammation. Depression is increasingly linked to the activation of immune cells in the brain called glial cells, to elevated inflammatory signaling molecules, and to dysfunction of the blood-brain barrier, the membrane that normally protects the brain from circulating immune factors.8PubMed Central. Neuroinflammation-A Crucial Factor in the Pathophysiology of Depression-A Comprehensive Review
This inflammatory process shows up even in adolescents. A study comparing teens with major depression to healthy controls found significantly elevated levels of certain inflammatory markers and demonstrated that a metabolite of the amino acid tryptophan could directly damage microglial cells, triggering them to release inflammatory signals.9PubMed. Peripheral cytokine dysregulation, microglial dysfunction in adolescent major depressive disorder: Neuroimmune crosstalk implications The gut also appears to play a role in this inflammatory cascade. In people with depression, changes in gut microbe composition can compromise the intestinal lining, allowing bacterial products and inflammatory signals to enter the bloodstream and ultimately cross into the brain, contributing to the kind of chronic neuroinflammation associated with depressive symptoms.10eBioMedicine. Role of gut microbiota and metabolites in depression
The Gut-Brain Connection
The relationship between gut bacteria and depression extends beyond inflammation. A large-scale study of the gut microbiome and depressive symptoms found that many of the bacterial species linked to depression were involved in producing neurotransmitter precursors, including glutamate, serotonin, GABA, and short-chain fatty acids like butyrate. Glutamate, the brain’s primary excitatory neurotransmitter, has been linked to mood disorders at abnormal levels, and is the target of newer antidepressants like ketamine. Butyrate can cross the blood-brain barrier and activate the vagus nerve and hypothalamus, and has shown antidepressant effects in animal models.11Nature Communications. Gut microbiome-wide association study of depressive symptoms
The gut produces more than 90% of the body’s serotonin, although that peripheral serotonin can’t cross directly into the brain. Still, gut-produced serotonin may influence brain chemistry indirectly by affecting blood-brain barrier permeability and stimulating the vagus nerve, which connects the gut directly to the brainstem. Animal studies show that germ-free mice (those lacking gut bacteria entirely) exhibit anxiety-like behaviors and altered brain serotonin levels, suggesting the microbiome plays a role in setting the brain’s baseline neurochemical state.
The Stress Axis and Circadian Disruption
Depression is tightly linked to a stress-hormone system called the hypothalamic-pituitary-adrenal (HPA) axis, which regulates cortisol release. In many people with depression, this system is chronically overactive. Excessive secretion of the stress hormone CRH, combined with impaired feedback that should normally shut cortisol production down, is considered one of the most reliable hallmarks of the neuroendocrine disruption associated with depressive disorders.12Brazilian Journal of Psychiatry. Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis Chronic cortisol elevation itself damages hippocampal neurons, which may partly explain the volume loss seen in imaging studies.
The body’s internal clock is also tangled up in the process. Circadian disruption has been associated with mood disorders, and depressed patients consistently show irregular biological rhythms in sleep, appetite, activity, and cortisol levels. This suggests that circadian timing is involved not just as a symptom of depression but potentially as part of its underlying cause.13PubMed. The role of the circadian system in the etiology of depression The relationship appears bidirectional: disrupted sleep worsens depressive symptoms, and depressive episodes disrupt sleep, creating a feedback loop that is difficult to break without addressing both sides.
What Stroke and Autoimmune Brain Disease Reveal
Some of the strongest evidence that depression has a neurological substrate comes from cases where brain damage directly produces depressive symptoms. After a stroke, depression is extremely common, and researchers have mapped which damaged areas correspond to which symptom clusters. Lesions in the prefrontal cortex and inferior frontal gyrus are linked to overall depression severity. Damage to the thalamus, anterior insula, and somatosensory cortex is associated with emotional symptoms like sadness. Lesions in the basal ganglia and orbitofrontal cortex are tied to motivational deficits. Cognitive symptoms like guilt and difficulty concentrating map to prefrontal damage, while somatic symptoms like appetite and sleep changes map to the insula and amygdala.14PubMed Central. Neuroanatomy of post-stroke depression: the association between symptom clusters and lesion location This level of anatomical specificity looks a lot like classical neurology.
Autoimmune encephalitis offers another window. In anti-NMDA receptor encephalitis, the immune system attacks glutamate receptors in the brain, and depressive symptoms are a prominent feature, particularly in patients with higher levels of the offending antibodies.15PubMed Central. Psychiatric Symptoms of Patients With Anti-NMDA Receptor Encephalitis Even after the acute phase of autoimmune encephalitis resolves, patients continue to report elevated depression, post-traumatic stress, and cognitive difficulties.16PubMed Central. Subjective psychiatric symptoms in post-acute autoimmune encephalitis: findings from the Australian autoimmune encephalitis consortium When you can produce depression by attacking specific brain receptors with antibodies, the condition looks neurological by any reasonable definition.
Depression in Parkinson’s Disease
The overlap between depression and recognized neurological conditions goes both ways. In Parkinson’s disease, clinically significant depression affects roughly a third of patients, with the risk about four times higher than in the general population matched for age and sex.17PubMed Central. Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment This isn’t just a psychological reaction to having a chronic illness. The depression in Parkinson’s appears to stem from the same dopaminergic, serotonergic, and noradrenergic degeneration that causes the movement symptoms. It often precedes the motor symptoms by years, suggesting it’s part of the disease’s neurobiology rather than a response to disability.
Treatments That Target the Brain Directly
If depression were purely a psychological phenomenon, you wouldn’t expect treatments that directly alter brain circuitry to work. But they do. Transcranial magnetic stimulation (TMS), which uses magnetic pulses to stimulate specific brain regions, produces symptom improvement that appears to involve changes in signaling between the prefrontal cortex, the anterior cingulate cortex, and salience-network regions.18PubMed. Mechanisms of Action of TMS in the Treatment of Depression The therapeutic target is a specific spot on the skull, and the mechanism involves rewiring communication between identifiable brain networks. That’s a neurological intervention by any standard.
Newer research on psychedelics and ketamine reinforces this picture. A single dose of psilocybin was found to increase dendritic spine density in the mouse frontal cortex by about 7% within a day and about 12% within a week, with spine heads growing wider as well.19PubMed Central. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo Psychedelics and ketamine both promote the growth of new neuronal branches and the formation of new synapses.20PubMed Central. Psychedelics Promote Structural and Functional Neural Plasticity The leading explanation for why these drugs produce rapid and sustained antidepressant effects is that they trigger a burst of neuroplasticity, particularly in prefrontal circuits, that may help rewire the disrupted connectivity underlying depressive states.21Trends in Pharmacological Sciences. Serotonergic and glutamatergic mechanisms converge in ketamine’s and psychedelics’ rapid antidepressant actions
Why We Still Don’t Have a Depression Blood Test
Given all these measurable brain changes, you might wonder why depression is still diagnosed by asking patients how they feel rather than by scanning their brains or running a blood panel. The short answer is that hundreds of potential biomarkers have been identified, spanning inflammatory markers, growth factors, metabolic signals, neurotransmitter levels, and neuroimaging patterns, but none has proven reliable enough on its own to serve as a diagnostic test.22PubMed Central. Biomarkers for depression: recent insights, current challenges and future prospects The problem is partly that depression is heterogeneous. Two people with the same clinical diagnosis may have very different underlying biology, making any single biomarker unreliable across the board.
Neuroimaging-based biomarkers are perhaps the most promising. Researchers have found that abnormal prefrontal activity during cognitive tasks can be measured objectively using changes in blood flow, and that machine learning can use these patterns to screen for depression at early stages.23PubMed Central. Identifying neuroimaging biomarkers of major depressive disorder from cortical hemodynamic responses using machine learning approaches The structures and functions of the anterior cingulate, prefrontal cortex, amygdala, and hippocampus are strong candidates for biomarkers that could predict treatment response.24PubMed Central. Promising Neuroimaging Biomarkers in Depression But translating these research findings into tools that work in a doctor’s office, at reasonable cost, for diverse patients, remains a major unsolved challenge. Until that translation happens, depression stays in the category of disorders diagnosed by their symptoms rather than their underlying pathology, which is one reason it keeps its psychiatric label.
How We Frame Depression Changes How People Experience It
The question of whether depression “is” neurological or psychiatric isn’t only an academic taxonomy dispute. How depression is framed has real consequences for the people living with it. Describing depression in purely biological terms, the “chemical imbalance” message, has been shown to reduce blame directed at people with the condition. But it also tends to reduce hope for recovery and increase a sense that the problem is permanent and fixed.25PubMed. Dissociable impacts of biological and functional framings of depression: an experimental approach
An alternative framing that treats depression as a signal serving an adaptive function, rather than purely a disease, appears to reduce self-stigma and increase people’s belief in their ability to recover. In a randomized trial, participants with depression histories who watched videos describing depression as a purposeful signal reported less self-stigma and more adaptive beliefs about the condition than those who watched standard “disease like any other” videos.26PubMed. Framing depression as a functional signal, not a disease: Rationale and initial randomized controlled trial This aligns with evolutionary models suggesting that depressed mood, at its core, may reflect an adaptive response to perceived threats of social exclusion, one that minimizes risky social interactions when outcomes feel unpredictable.27Trends in Cognitive Sciences. An Active Inference Approach to Homeostatic and Adaptive Affective States
None of this means depression isn’t a serious medical condition that involves brain dysfunction. It clearly is. But telling people “your brain is broken” carries costs that a more nuanced framing, one that acknowledges both the biological reality and the potential meaningfulness of the experience, may avoid. The science is increasingly pointing toward depression as a condition that involves the brain as deeply as any recognized neurological disorder, while also involving layers of psychological and social complexity that pure neurology doesn’t capture well. The categories we inherited from 19th-century medicine were never designed to handle something like that, and they’re starting to show their age.